|
Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity.
Blood. 2004 May; 103(10):3677-83. Epub 2004 Ene 15
Rajagopalan S, Somers EC, Brook RD, Kehrer C, Pfenninger D, Lewis E, Chakrabarti A, Richardson BC, Shelden E, McCune WJ, Kaplan MJ |
|
Allosteric Changes in Solvent Accessibility Observed in Thrombin upon Active Site Occupation.
Biochemistry. 2004 May; 43(18):5246-55.
Croy CH, Koeppe JR, Bergqvist S, Komives EA |
|
Contribution of Factor VIIIa A2 and A3-C1-C2 Subunits to the Affinity for Factor IXa in Factor Xase.
Biochemistry. 2004 May; 43(17):5094-101.
Jenkins PV, Dill JL, Zhou Q, Fay PJ. |
|
The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
Thromb Haemost. 2004 May; 91(5):977-85.
Gerotziafas GT, Chakroun T, Depasse F, Arzoglou P, Samama MM, Elalamy I. |
|
A review of the therapeutic uses of thrombin.
Thromb Haemost. 2004 May; 91(5):851-60.
Lundblad RL, Bradshaw RA, Gabriel D, Ortel TL, Lawson J, Mann KG |
|
Binding of heparin to plasma proteins and endothelial surfaces is inhibited by covalent linkage to antithrombin.
Thromb Haemost. 2004 May; 91(5):1009-18.
Chan AK, Paredes N, Thong B, Chindemi P, Paes B, Berry LR, Monagle P. |
|
Injection of recombinant activated factor VII can induce transient increase in circulating procoagulant microparticles.
Thromb Haemost. 2004 May; 91(5):873-8.
Proulle V, Hugel B, Guillet B, Trichet C, Rafowicz A, Lambert T, Freyssinet JM, Dreyfus M |
|
Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke.
Thromb Haemost. 2004 May; 91(5):1031-4.
Aznar J, Mira Y, Vaya A, Corella D, Ferrando F, Villa P, Estelles A |
|
Functional characterization of factor V-Ile359Thr: a novel mutation associated with thrombosis.
Blood. 2004 May; 103(9):3381-7. Epub 2003 Dic 24
Steen M, Norstrom EA, Tholander AL, Bolton-Maggs PH, Mumford A, McVey JH, Tuddenham EG, Dahlback B |
|
Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease.
Stroke. 2004 May; 35(5):1085-9. Epub 2004 Mar 11
Paramo JA, Orbe J, Beloqui O, Benito A, Colina I, Martinez-Vila E, Diez J |
|
Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk.
Thromb Haemost. 2004 May; 91(5):905-11.
Medina P, Navarro S, Estelles A, Vaya A, Woodhams B, Mira Y, Villa P, Migaud-Fressart M, Ferrando F, Aznar J, Bertina RM, Espana F. |
|
FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production.
Circ Res.. 2004 Abr; 94(8):1032-40. Epub 2004 Mar 11
Versteeg HH, Spek CA, Slofstra SH, Diks SH, Richel DJ, Peppelenbosch MP |
|
Kinetics of factor X activation by the membrane-bound complex of factor IXa and factor VIIIa.
Biochem J. 2004 Abr; Epub ahead of print Feb
Panteleev MA, Saenko EL, Ananyeva NM, Ataullakhanov FI |
|
Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity.
Blood. 2004 Abr; 103(8):3038-44.
Dietzen DJ, Page KL, Tetzloff TA. |
|
Augmented intrinsic activity of Factor VIIa by replacement of residues 305, 314, 337 and 374: evidence of two unique mutational mechanisms of activity enhancement.
Biochem J.. 2004 Abr; 379(pt2):497-503.
Persson E, Bak H, Ostergaard A, Olsen OH. |
|
Trp2063 and trp2064 in the factor Va C2 domain are required for high-affinity binding to phospholipid membranes but not for assembly of the prothrombinase complex.
Biochemistry. 2004 Abr; 43(14):4385-93.
Peng W, Quinn-Allen MA, Kim SW, Alexander KA, Kane WH |
|
Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
Biochemistry. 2004 Abr; 43(14):4150-9.
Isetti G, Maurer MC |
|
Lupus-derived antiprothrombin autoantibodies from a V gene phage display library are specific for the kringle 2 domain of prothrombin.
Biochemistry. 2004 Abr; 43(13):4047-54.
Le A, Dasgupta S, Planque S, Paul S, Thiagarajan P. |
|
Oral contraceptive use in women with poor anticoagulant response to activated protein C but not carrying the factor V Leiden mutation increases the risk of venous thrombosis.
Thromb Haemost. 2004 Abr; 91(4):712-8.
Legnani C, Cini M, Cosmi B, Mattarozzi S, Lo Manto G, Palareti G. |
|
Treatment with anticoagulants in cerebral events (TRACE).
Thromb Haemost. 2004 Abr; 91(4):690-3.
Woessner R, Grauer M, Bianchi O, Mueller M, Moersdorf S, Berlit P, Goertler M, Grotemeyer KH, Sliwka U, Stoll M, Treib J. |
